Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

Market Cap	6.66B +1.5%
Revenue (ttm)	3.11B +15.3%
Net Income	95.72M -5.8%
EPS	0.28 -3.4%
Shares Out	343.93M
PE Ratio	68.97
Forward PE	21.29
Dividend	0.05 (0.26%)
Ex-Dividend Date	n/a

Volume	1,851,100
Average Volume	2,966,516
Open	19.70
Previous Close	19.37
Day's Range	19.15 - 19.70
52-Week Range	19.07 - 31.20
Beta	0.45
RSI	26.32
Earnings Date	Apr 24, 2026

About SHE:300702

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 4,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300702

Financial Performance

In 2025, SHE:300702's revenue was 3.06 billion, an increase of 16.36% compared to the previous year's 2.63 billion. Earnings were 139.71 million, an increase of 149.78%.